Novel Mutation in CECR1 Leads to Deficiency of ADA2 with Associated Neutropenia
JOURNAL OF CLINICAL IMMUNOLOGY, vol.38, no.3, pp.273-277, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 38 Issue: 3
- Publication Date: 2018
- Doi Number: 10.1007/s10875-018-0487-x
- Journal Name: JOURNAL OF CLINICAL IMMUNOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.273-277
- Keywords: ADA2, deficiency of adenosine deminase 2, neutropenia, ADENOSINE-DEAMINASE 2, CONGENITAL NEUTROPENIA, PROTEIN, GENE, VASCULOPATHY, PHENOTYPE
- Istanbul University Affiliated: Yes
Abstract
Adenosine deaminase 2 (ADA2) have been reported to cause vasculitic diseases and immunodeficiency recently. Patients present with stroke episodes and rashes mimicking polyarteritis nodosa (PAN). We report a patient who has been followed up with severe neutropenia and found an unexpectedly revealed novel mutation in CECR1 affecting ADA2.